Highly sensitive detection of anti-cancer drug based on bimetallic reduced graphene oxide nanocomposite

Carbon Nanomaterials-Based Novel Hybrid Platforms for Electrochemical Sensor Applications in Drug Analysis

Nowadays, the rapid improvements in the medical and pharmaceutical fields increase the diversity and use of drugs. However, problems such as the use of multiple or combined drugs in the treatment of diseases and insensible use of over-the-counter drugs have caused concerns about the side-effect profiles and therapeutic ranges of drugs and environmental contamination and pollution problems due to pharmaceuticals waste. Therefore, the analysis of drugs in various media such as biological, pharmaceutical, and environmental samples is an important topic of discussion. Electrochemical methods are advantageous for sensor applications due to their easy application, low cost, versatility, high sensitivity, and environmentally-friendliness. Carbon nanomaterials such as diamond-like carbon thin films, carbon nanotubes, carbon nanofibers, graphene oxide, and nanodiamonds are used to enhance the performance of the electrochemical sensors with catalytic effects. To further improve this effect, it is aimed to create hybrid platforms by using different carbon nanomaterials together or with materials such as conductive polymers and ionic liquids. In this review, the most used carbon nanoforms will be evaluated in terms of electrochemical characterizations and physicochemical properties. Furthermore, the effect of hybrid platforms developed in the most recent studies on electrochemical sensors will be examined and evaluated in terms of drug analysis studies in the last five years.

Electrochemical peptide-based biosensor for the detection of the inflammatory disease biomarker, interleukin-1beta

This paper reports the development of a highly sensitive and selective electrochemical peptide-based biosensor for the detection of the inflammatory disease biomarker, interleukin-1beta (IL-1β). To this end, flower-like Au-Ag@MoS2-rGO nanocomposites were used as the signal amplification platform to achieve a label-free biosensor with a high sensitivity and selectivity. First, a high-affinity peptide for IL-1β was identified through biopanning with M13 random peptide libraries, and was newly designed by incorporating cysteine at the C-terminus. An IL-1β specific binding peptide was used as the bio-receptor, and the interaction between the IL-1β binding peptide and IL-1β was confirmed via enzyme-linked immunosorbent assay and various physicochemical and electrochemical analyses. Under optimal conditions, the biosensor achieved an ultrasensitive and specific IL-1β detection in a wide linear concentration range of 0-250 ng/mL with a picomolar-level detection limit (∼2.4 pM), low binding constant (∼0.62 pM), and a low coefficient of variation (<1.65 %). The biosensor was successfully utilized for IL-1β determination in the serum of Crohn's disease patients with a good correlation coefficient. In addition, the detection performance was comparable to that of commercially available IL-1β ELISA kit. This indicates that the electrochemical peptide-based biosensor may offer a potentially valuable platform for the clinical diagnosis of various inflammatory disease biomarkers.

Regorafenib: A comprehensive drug profile

Regorafenib is a small molecule tyrosine kinase inhibitor administered orally drug, act by inhibiting the activity of the VEGF receptors. It is used for the treatment of patients with metastatic colorectal cancer (CRC), advanced gastrointestinal stromal tumors, and hepatocellular carcinoma. This comprehensive profile on regorafenib includes an original data as well as data collected from the literature on Profiles of Methods of Drug Synthesis, different Physical Drug Profiles, Drug Analytical methods and Pharmacological profile (ADME). This chapter is divided into five main sections: General Description of the drug, Physical Characteristics, Methods of Preparation, Methods of Analysis, Pharmacology and List of References. These main sections are further divided to many sub-titles to cover most aspect of the drug in the light of the available literature. Among these sub-titles are the formulae, Elemental Analysis, physical characteristics which include constant of ionization, solubility, X-ray powder diffraction pattern, TGA, thermal conduct and spectroscopic and stability. Additionally, analytical techniques including Electrochemical, Spectrophotometric and chromatographic methods, ADME profiles and pharmacological effects were also discussed. Furthermore, methods and schemes are outlined for the preparation of the drug substance.

Advances of Nanotechnology in the Diagnosis and Treatment of Hepatocellular Carcinoma

Nanotechnology has emerged as a promising technology in the field of hepatocellular carcinoma (HCC), specifically in the implementation of diagnosis and treatment strategies. Nanotechnology-based approaches, such as nanoparticle-based contrast agents and nanoscale imaging techniques, have shown great potential for enhancing the sensitivity and specificity of HCC detection. These approaches provide high-resolution imaging and allow for the detection of molecular markers and alterations in cellular morphology associated with HCC. In terms of treatment, nanotechnology has revolutionized HCC therapy by enabling targeted drug delivery, enhancing therapeutic efficacy, and minimizing off-target effects. Nanoparticle-based drug carriers can be functionalized with ligands specific to HCC cells, allowing for selective accumulation of therapeutic agents at the tumor site. Furthermore, nanotechnology can facilitate combination therapy by co-encapsulating multiple drugs within a single nanoparticle, allowing for synergistic effects and overcoming drug resistance. This review aims to provide an overview of recent advances in nanotechnology-based approaches for the diagnosis and treatment of HCC. Further research is needed to optimize the design and functionality of nanoparticles, improve their biocompatibility and stability, and evaluate their long-term safety and efficacy. Nonetheless, the integration of nanotechnology in HCC management holds great promise and may lead to improved patient outcomes in the future.

Review on Surface-Modified Electrodes for the Enhanced Electrochemical Detection of Selective Serotonin Reuptake Inhibitors (SSRIs)

Selective serotonin re-uptake inhibitors (SSRIs) are one of the most commonly prescribed classes of antidepressants used for the treatment of moderate to severe depressive disorder, personality disorders and various phobias. This class of antidepressants was created with improved margins of safety. However, genetic polymorphism may be responsible for the high variability in patients' responses to treatment, ranging from failure to delayed therapeutic responses to severe adverse effects of treatment. It is crucial that the appropriate amount of SSRI drugs is administered to ensure the optimum therapeutic efficacy and intervention to minimise severe and toxic effects in patients, which may be the result of accidental and deliberate cases of poisoning. Determining SSRI concentration in human fluids and the environment with high sensitivity, specificity and reproducibility, and at a low cost and real-time monitoring, is imperative. Electrochemical sensors with advanced functional materials have drawn the attention of researchers as a result of these advantages over conventional techniques. This review article aims to present functional materials such as polymers, carbon nanomaterials, metal nanomaterials as well as composites for surface modification of electrodes for sensitive detection and quantification of SSRIs, including fluoxetine, citalopram, paroxetine, fluvoxamine and sertraline. Sensor fabrication, sensor/analyte interactions, design rationale and properties of functional material and the electrocatalytic effect of the modified electrode on SSRI detection are discussed.

A facile fabrication of ratiometric electrochemical sensor for sensitive detection of riboflavin based on hierarchical porous biochar derived from KOH-activated Soulangeana sepals

Herein, a facile ratiometric electrochemical method was developed for sensitive sensing of riboflavin (RF) based on hierarchical porous biochar (HPB) modified electrode. In this sensing system, the reference paracetamol (PA) was directly added into electrolyte solution without the requirement of complex immobilization process. HPB derived from KOH-activated Soulangeana sepals displays hierarchical porous structure, high specific surface area and rich oxygen-containing functional groups, which is favorable for RF adsorption and enrichment. Besides, the excellent electronic conductivity and superior electrocatalytic activity of HPB can effectively promote the electrooxidation of RF. Moreover, the dual-signal strategy greatly improves the reproducibility and reliability of electrochemical detection. Based on the proposed ratiometric sensing platform, the sensor exhibits a wider linear range of 0.0007-10μM and a lower limit of detection of 0.2 nM. The method also presents good selectivity and has been applied to the determination of RF in milk samples with satisfactory results.

Strategies, advances, and challenges associated with the use of graphene-based nanocomposites for electrochemical biosensors

Graphene is an intriguing two-dimensional honeycomb-like carbon material with a unique basal plane structure, charge carrier mobility, thermal conductivity, wide electrochemical spectrum, and unusual physicochemical properties. Therefore, it has attracted considerable scientific interest in the field of nanoscience and bionanotechnology. The high specific surface area of graphene allows it to support high biomolecule loading for good detection sensitivity. As such, graphene, graphene oxide (GO), and reduced GO are excellent materials for the fabrication of new nanocomposites and electrochemical sensors. Graphene has been widely used as a chemical building block and/or scaffold with various materials to create highly sensitive and selective electrochemical sensing microdevices. Over the past decade, significant advancements have been made by utilizing graphene and graphene-based nanocomposites to design electrochemical sensors with enhanced analytical performance. This review focus on the synthetic strategies, as well as the structure-to-function studies of graphene, electrochemistry, novel multi nanocomposites combining graphene, limit of detection, stability, sensitivity, assay time. Finally, the review describes the challenges, strategies and outlook on the future development of graphene sensors technology that would be usable for the internet of things are also highlighted.

Ti3C2Tx (MXene)/Pt nanoparticle electrode for the accurate detection of DA coexisting with AA and UA

Dopamine (DA), uric acid (UA) and ascorbic acid (AA) are biomolecules widely distributed in the human body and play an important role in many physiological processes. An abnormal concentration of them is associated with various diseases. Thus, the accurate and fast detection of them has been one of the major demands in the healthcare industry. In this study, we demonstrate that Ti₃C₂T_x/PtNP modified glassy carbon electrodes (GCEs) show a good electrochemical performance in the detection of DA and UA. However, there is no response signal to AA for either the CV or DPV curve due to the electrostatic repulsion between the negatively charged electrode surface and the negatively charged AA. Ti₃C₂T_x(MXene)/Pt nanoparticles (PtNPs) are prepared by etching Ti₃AlC₂(MAX) with HF and reducing H₂PtCl₆ with a NaBH₄ aqueous solution. The morphology of Ti₃C₂T_x/PtNPs is multilayered accordion-like Ti₃C₂T_x decorated with PtNPs with a diameter of 10-20 nm. Furthermore, it is found that the electrochemical detection of DA will be enhanced by AA. The electrochemical detection rule of AA enhanced DA can be expressed as follows: I_(DA+AA) = 0.011216C_AA + 0.039950C_DA + 1.1175(I_(DA+AA) is the peak current of DA coexisting with AA. C_AA is the concentration of AA. C_DA is the concentration of DA). This can be used as a calibration to correct the concentration of DA when AA and DA coexist. Notably, AA promotes the stability of the electrode because it cleans the oxidation products from the electrode surface in time. In addition, the sensor exhibits good reproducibility and satisfactory recovery results in a real sample.

A 2D/2D NiCo-MOF/Ti3C2 heterostructure for the simultaneous detection of acetaminophen, dopamine and uric acid by differential pulse voltammetry

A 2D/2D NiCo-MOF/Ti₃C₂ heterojunction is constructed as a non-enzymatic biosensor for the simultaneous electrochemical detection of acetaminophen (AP), dopamine (DA), and uric acid (UA) via differential pulse voltammetry. Benefiting from the synergistic effects of the high electrocatalytic activity of NiCo-MOF, the outstanding conductivity of Ti₃C₂, and the improved specific surface area of NiCo-MOF/Ti₃C₂, NiCo-MOF/Ti₃C₂ displays high sensing performance toward AP (0.01-400 μM), DA (0.01-300 μM), and UA (0.01-350 μM) in 0.1 M phosphate buffer (PB, pH 7.4) at working potentials of 0.346 V vs. SCE for AP, 0.138 V vs. SCE for DA, and 0.266 V vs. SCE for UA. Furthermore, the well-separated oxidation peak potentials allow for the simultaneous detection of the analytes, with detection limits of 0.008, 0.004, and 0.006 μM (S/N = 3), respectively. As a result of its considerable reproducibility and anti-interference and anti-fouling properties, NiCo-MOF/Ti₃C₂ was also developed into a practical sensing platform to detect AP, DA, and UA in serum and urine, presenting excellent recoveries of 98.1-102.2 %.